Holiday safety interviews available now
December 11, 2012
ER physicians can discuss variety of health-related topics
For Latinas, patient navigation can speed breast cancer diagnosis
December 11, 2012
Results of UT Health Science Center study published in the journal Cancer
CPRIT funds study of drug resistance in glioblastomas
December 7, 2012
Studies of how to overcome drug resistance in deadly central nervous system tumors called glioblastomas will propel forward thanks to $755,718 from the Cancer Prevention & Research Institute of Texas.
UT Health Science Center San Antonio spin-out company Rapamycin Holdings licenses drug’s intellectual property
December 7, 2012
The ability of rapamycin-related drugs to potentially slow the aging process — suggested in animal experiments at The University of Texas Health Science Center San Antonio — has led to establishment of a new San Antonio biotech company, Rapamycin Holdings Inc., which is licensing exclusive rights to intellectual property central to several aspects of the rapamycin-related drugs.
Study: Newer technology improves detection of stillbirth cause
December 6, 2012
A tool called microarray testing can help doctors to more often pinpoint the potential genetic reason for a stillbirth, so that more couples can learn what happened to their babies, a study of 500 stillbirths in San Antonio and four other cities showed.
M.D./Ph.D. students, Baptist nursing students celebrate Adler family’s gift of $1.5 million
December 6, 2012
Doctoral students, nursing students, and officials of the UT Health Science Center San Antonio and the Baptist Health Foundation of San Antonio are celebrating $1.5 million in gifts from the estate of Laura A. Adler in memory of her husband, Harry F. Adler, M.D., Ph.D.